Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q1 FY2027 Earnings Presentation
21 slides from Aarti Industries's earnings presentation, Jul 30, 2026
Slide 1: Results Presentation filing letter to stock exchanges
July 30, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. BSE CODE : 524208
Slide 2: Q1 FY27 Performance Update
A Legacy of Q1 FY27 Excellence Performance Update A Future of 30 July, 2026 Possibilities
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Index
Company overview Index Q1 FY27 Highlights Future Outlook and Roadmap
Slide 5: Index
Company overview Index Q1 FY27 Highlights Future Outlook and Roadmap
Slide 6: Aarti Industries at a Glance
Aarti Industries at a Glance Established by first generation technocrats in 1984 Benzene based Feedstock Assurance and Downstream Products Supply Integrated operations and high-cost optimization Toluene based Technology Sharing Key value chains include Nitro Chloro Benzenes, Downstream Products Spec
Slide 7: Our Ethos
Our Ethos AIL VALUES PURPOSE Right Chemistry for a Brighter Tomorrow VISION To emerge as a Global Partner of Choice for leading consumers of speciality chemicals and intermediates MISSION Delighted Stakeholders CARE INTEGRITY EXCELLENCE 6
Slide 8: Index
Company overview Index Q1 FY27 Highlights Future Outlook and Roadmap
Slide 9: Business Highlights Q1 FY27
Business Highlights Q1 FY27 Sustainability Partnerships Volumes Growth Ecovadis | AIL secured a Platinum rating ● Existing Long Term contracts progressing well ● Capacity expansion from 290 to 360 kTPA with a score of 87 out of 100 placing us and remain stable for fuel additives completed in July 20
Slide 10: Q1FY27 Highlights (Consolidated)
Q1FY27 Highlights (Consolidated) ₹ in Cr Revenue increased due to - YoY: 41% ▲ QoQ: 8% ▲ YoY: 79% ▲ QoQ: 13% ▲ YoY: 260% ▲ QoQ: 13% ▲ Revenue increase primarily driven by higher input prices passed on to customers Business Volumes (Q1) Energy Non-Energy YoY: 57% ▲ YoY: 12% ▲ QoQ: 17%▼ QoQ: 7% ▼ Midd
Slide 11: Capacity utilization for major product groups
> 85% Capacity utilization for major product groups 65 - 85% < 65% Product Groups Capacity (in KTPA) FY25 FY26 Q1 FY27 NCB 108 DCB 120 Hydrogenation 60 PDA 12 NT 45 Ethylation 25 - 30 Methylation 360 (from July 2026) (Fuel additives) Fuel Additives Capacity DCB Debottlenecking Capacity expansion fro
Slide 12: Revenue by End Use
Revenue by End Use ₹ Cr 8046 1867 2422 9018 2627 Agrochemicals & Fertilizers (18%) Stable demand continues across application segments, though margin and pricing Agrochemicals & pressure remains persistent in select products 18% 18% 19% 18% 18% Fertilizers Dyes, Pigments & Printing Inks (15%) Dyes,
Slide 13: Application wise market updates & business highlights (1/2)
Application wise market updates & business highlights (1/2) End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share 18% 18% 38% 38% Domestic Export Domestic Export Domestic / Exports 58% 42% 6% 9
Slide 14: Application wise market updates & business highlights (2/2)
Application wise market updates & business highlights (2/2) Dyes, Pigments & Printing End Use Pharmaceuticals Polymer and additives Inks PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share 15% 15% 14% 14% 11% 11% Domestic Domestic Export Export Domestic Dome
Slide 15: Joint Ventures
Joint Ventures DCA downstream JV with Superform Project at near commissioning stage. Expected commercialisation in Q2FY27 Tailwinds in one of the end applications being witnessed; may support quicker capacity utilization Marketing efforts initiated in line with the commissioning timelines Chemical R
Slide 16: Index
Company overview Index Q1 FY27 Highlights Future Outlook and Roadmap
Slide 17: Key EBITDA Growth Drivers in 3 year plan (FY25 - FY28)
Key EBITDA Growth Drivers in 3 year plan (FY25 - FY28) Cost Optimisation Volume and margin ramp-up CAPEX-led growth ₹ 150-200 crore ₹ 350-550 crore ₹ 300-450 crore Switching to Back Pressure Turbine to Acid, DCB & NCB value chain Pilot commissioned to fuel New improve Cogen ramp-up Product Developme
Slide 18: Long term growth focus areas
Long term growth focus areas MPP and Zone 4 Commercialization • R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries • Chlorotoluene commissioning and ramp up will open up new opportunities in Agro and Pharma business segments New Growth Avenues
Slide 19: Growth Outlook
Growth Outlook EBITDA, ₹ Cr 1800 - 2200 Deliver consistent volume growth over 3 yrs driven by increased capacities, despite margin pressures Operating leverages and cost optimisation initiatives to drive EBITDA growth beyond volume growth Zone IV projects delayed by 2 Quarters due to labour constrai
Slide 20: Certifications
wr w “* Certifications @)) aan INDUSTRIES Fannum PSS ELS ecovadis \ SS tocetHer Iso coe Suelis SUSTAINABILITY JUN 2026 ~ Nie’ 1S0 45001:2018 Ks ? 90093015 Responsible Care” {un coMNITHENT To SUSTANABILTY 14001
Slide 21: Thank You
investorrelations@aarti-industries.com Thank You